AG
MXCT icon

Algert Global’s MaxCyte MXCT Stock Holding History

Algert Global’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-81,625
Closed -$318K – 1276
2024
Q3 		$318K Sell
81,625
-120,810
-60% -$509K 0.01% 987
2024
Q2 		$794K Sell
202,435
-6,580
-3% -$28.3K 0.03% 743
2024
Q1 		$876K Buy
+209,015
New +$981K 0.03% 645
2023
Q4 		– Sell
-138,798
Closed -$433K – 1208
2023
Q3 		$433K Sell
138,798
-21,330
-13% -$85.8K 0.02% 790
2023
Q2 		$735K Sell
160,128
-245,155
-60% -$1.13M 0.03% 724
2023
Q1 		$2.01M Buy
405,283
+312,929
+339% +$1.54M 0.09% 348
2022
Q4 		$504K Buy
92,354
+48,420
+110% +$297K 0.03% 802
2022
Q3 		$286K Buy
+43,934
New +$245K 0.02% 957

Other funds holding MXCT

CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
RGI
River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Algert Global's MXCT Position: Q4 2024 in Review

Algert Global sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 81,625 shares — an estimated $318K sold.

Algert Global first reported a position in MXCT in Q3 2022 and held it in 8 quarters. The position peaked at $2.01M in Q1 2023. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

  • Algert Global reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
  • Algert Global sold 81,625 MaxCyte shares in Q4 2024, an estimated $318K.
  • Algert Global first reported a position in MaxCyte in Q3 2022 and held it in 8 quarters.
  • Algert Global's MaxCyte position peaked at $2.01M in Q1 2023.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on Algert Global's 13F filing for Q4 2024, filed 14 Feb 2025.